Attached files

file filename
10-K - FORM 10-K - Adhera Therapeutics, Inc.t1600825_10k.htm
EX-21.1 - EXHIBIT 21.1 - Adhera Therapeutics, Inc.t1600825_ex21-1.htm
EX-31.1 - EXHIBIT 31.1 - Adhera Therapeutics, Inc.t1600825_ex31-1.htm
EX-32.1 - EXHIBIT 32.1 - Adhera Therapeutics, Inc.t1600825_ex32-1.htm

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statement No. 333-200836 on Form S-8 of Marina Biotech, Inc. of our report dated March 30, 2016 with respect to the consolidated financial statements, which appear in this Annual Report on Form 10-K of Marina Biotech, Inc. for the year ended December 31, 2015.

 

/s/ Wolf & Company, P.C.

 

Wolf & Company, P.C. 

Boston, Massachusetts

March 30, 2016